Prof. Li Min’s research postgraduate student Miss. Wang Ziying from Mr. & Mrs. Ko Chi Ming Centre for Parkinson's Disease Research passed her Ph.D. thesis Oral examination on 13th August, 2019. Her research involves using TFEB activator E4 as a potential treatment of Parkinson’s disease. Previously, Prof. Li Min’s research team has identified E4 as a TFEB activator. Miss Wang Ziying’s Ph.D. research confirmed that E4 is an autophagy inducer and its anti-Parkinsonian effect in both in vitro and Parkinson’s disease mouse model. This work was published in the Journal of Molecular Science.

(Left to right): Dr. Yang Zhijun, Associate Professor of the School of Chinese Medicine, Hong Kong Baptist University; Dr. KWAN Hiu Yee, Associate Professor of the School of Chinese Medicine, Hong Kong Baptist University; Prof. Li Min, Wang Ziying’s principal supervisor, Associate Dean of School of Chinese Medicine, Hong Kong Baptist University, Director of Mr. & Mrs. Ko Chi Ming Centre for Parkinson's Disease Research; Prof. Lin Zhixiu, Associate Director of School of Chinese Medicine, The Chinese University of Hong Kong; Miss Wang Ziying; Prof. Zuo Zhong, Joan, Director and Professor, School of Pharmacy, The Chinese University of Hong Kong; Dr. Han Quanbin, Assistant Professor of the School of Chinese Medicine, Hong Kong Baptist University; Dr. Cheung King Ho, Associate Professor of the School of Chinese Medicine, Hong Kong Baptist University.